6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF A FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934

For October 14, 2009

ASML Holding N.V.

De Run 6501
5504 DR Veldhoven
The Netherlands
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F þ     Form 40-F o

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o     No þ

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

EXHIBITS 99.1, 99.3 AND 99.4 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-13332), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-105600), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-109154), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-142254), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277), AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-162439) OF ASML HOLDING N.V.

TABLE OF CONTENTS

	Exhibits
	SIGNATURES
EX-99.1
EX-99.2
EX-99.3
EX-99.4

Exhibits

99.1	“ASML Announces 2009 Third Quarter Results — Sales and Orders Rise as Chip Industry Executes Technology Investment Strategy,” press release dated October 14, 2009
99.2	“ASML 2009 Third Quarter Results — Sales and Orders Rise as Chip Industry Executes Technology Investment Strategy,” presentation dated October 14, 2009
99.3	Summary U.S. GAAP Consolidated Statements of Operations
99.4	Summary IFRS Consolidated Statements of Operations

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

2

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASML HOLDING N.V. (Registrant)
Date: October 14, 2009	By:	/s/ Peter T.F.M. Wennink
		Peter T.F.M. Wennink
		Executive Vice President and Chief Financial Officer

3

EX-99.1

Exhibit 99.1

Media Relations Contact
Lucas van Grinsven — Corporate Communications — +31 40 268 3949 — Veldhoven, the Netherlands

Investor Relations Contacts
Craig DeYoung — Investor Relations — +1 480 383 4005 — Tempe, Arizona, USA
Franki D’Hoore — Investor Relations — +31 40 268 6494 — Veldhoven, the Netherlands

ASML announces 2009 Third Quarter Results

Sales and orders rise as chip industry executes technology investment strategy

VELDHOVEN, the Netherlands, October 14, 2009 — ASML Holding NV (ASML) today announces 2009 third quarter results according to US GAAP as follows:

• Q3 2009 net sales of EUR 555 million versus Q2 2009 net sales of EUR 277 million (Q3 2008 net sales of EUR 696 million).

• Q3 2009 operating income of EUR 39 million, or 6.9 percent of net sales, versus a Q2 2009 operating loss of EUR 124 million or 45.0 percent of net sales (Q3 2008 operating income of EUR 83 million or 12.0 percent of net sales).

• Q3 2009 net income of EUR 20 million, or 3.6 percent of net sales, versus a Q2 2009 net loss of EUR 104 million or 37.6 percent of net sales (Q3 2008 net income of EUR 73 million or 10.5 percent of net sales).

• Q3 2009 net bookings valued at EUR 777 million with 35 systems including 27 new and 8 used systems, leading to an order backlog valued at EUR 1,353 million as of September 27, 2009.

“ASML’s third quarter sales doubled from the second quarter, stemming from technology transition demand for our state-of-the-art immersion lithography systems as new DRAM devices are introduced and as Foundry customers are ramping 40 nanometer (nm) products,” said Eric Meurice, president and Chief Executive Officer of ASML. “We shipped our first NXT:1950i system, offering best-in-class overlay of less than three nanometers and improved imaging, enabling the next generation of semiconductors with

Page 1 of 5

patterning below 30 nm. We kept a close rein on costs and retained a healthy cash position above EUR 1 billion even as we invest in working capital to prepare for sales growth,” Meurice added.

Operations Update

In Q3 2009, ASML’s net sales of EUR 555 million included 17 new and 7 used systems, resulting in net system sales of EUR 459 million, and net service and field options sales of EUR 96 million. Net system sales for Q2 2009 included the shipment of 4 new and 6 used machines, totaling EUR 183 million, and net service and field options sales of EUR 94 million.

The Q3 2009 average selling price for a new system was EUR 23.4 million, compared with the Q2 2009 average selling price for a new system of EUR 31.1 million as a result of a blend of immersion and non-immersion systems. The Q3 2009 average selling price for all ASML systems sold was EUR 19.1 million, compared with the Q2 2009 average selling price for all systems sold of EUR 18.3 million.

Q3 2009 net bookings totaled 35 systems valued at EUR 777 million, including 18 immersion systems.

ASML’s order backlog as of September 27, 2009 was EUR 1,353 million, totaling 54 systems with an average selling price of EUR 25.1 million. ASML’s backlog as of June 28, 2009 was valued at EUR 1,064 million, totaling 43 systems with an average selling price of EUR 24.7 million.

In Q3 2009, ASML generated net income of EUR 20 million, or EUR 0.05 per ordinary share as compared with a net loss in Q2 2009 of EUR 104 million or EUR 0.24 per ordinary share.

The company’s Q3 2009 gross margin was 34.4 percent, compared with the Q2 2009 gross margin of 12.5 percent, reflecting the better coverage of fixed production costs as a result of increased sales.

Page 2 of 5

Q3 2009 R&D costs were EUR 115 million net of credits, versus EUR 118 million in Q2 2009.

Selling, general and administrative (SG&A) costs were EUR 38 million in Q3 2009, compared with EUR 41 million SG&A costs in Q2 2009.

Net cash used in operations was EUR 65 million in Q3 2009 as increasing sales result in higher accounts receivable. ASML ended Q3 2009 with EUR 1,018 million in cash and cash equivalents, compared with EUR 1,093 million at the end of Q2 2009.

Outlook

“We booked 35 systems worth EUR 777 million in the third quarter, nearly twice the level booked in the second quarter; this level reflects accelerated technology investments in the DRAM memory and Foundry segments after a nine month period of very low capital spending,” Meurice said. “This recovery mainly supports new Integrated Circuits product introductions, not so much an overall significant wafer capacity increase. ASML’s Q3 order intake, and that of Q4 which we expect to be at least of similar value, is for deliveries in the first half of 2010 and will translate into significant sales growth versus Q3 levels. This substantial order increase does not factor in a full worldwide economic recovery, which, if it materializes, could sustain the first half sales level into the second half of 2010,” Meurice added.

ASML expects Q4 2009 net sales of around EUR 550 million and gross margin in Q4 2009 of about 37 percent. R&D expenditures are expected to be at EUR 115 million net of credits and SG&A costs are expected at EUR 37 million. We expect our cash balance in Q4 2009 to be at a similar level as per end-Q3, even as we prepare to ramp NXT shipments in the first half of 2010 and to build EUV systems planned for delivery in the second half of 2010.

About ASML

ASML is the world’s leading provider of lithography systems for the semiconductor industry, manufacturing complex machines that are critical to the production of

Page 3 of 5

integrated circuits or chips. Headquartered in Veldhoven, the Netherlands, ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. ASML has more than 6,500 employees (expressed in full time equivalents), serving chip manufacturers in more than 60 locations in 15 countries. For more information, visit our website: www.asml.com

Investor and Media Conference Call

A conference call for investors and media will be hosted by CEO Eric Meurice and CFO Peter Wennink at 15:00 PM Central European Time / 09:00 AM Eastern U.S. time. Dial-in numbers are: in the Netherlands +31 70 304 3371 and the US +1 706 679 0473. To listen to the conference call, access is also available via www.asml.com

A presentation about 2009 third quarter results is available on www.asml.com

A video statement of CFO Peter Wennink is available on www.asml.com

A replay of the Investor and Media Call will be available on www.asml.com

IFRS Financial Reporting

ASML’s primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows, consolidated balance sheets, and a reconciliation of net income/(loss) and equity from US GAAP to IFRS as adopted by the European Union (IFRS) are available on www.asml.com

In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of share-based payment plans, the accounting of income taxes and the accounting of reversal of inventory write-downs. Quarterly IFRS consolidated income statements, consolidated statements of cash flows,

Page 4 of 5

consolidated statements of financial position and a reconciliation of net income/(loss) and equity from US GAAP to IFRS are available on www.asml.com

The consolidated balance sheets of ASML Holding N.V. as of September 27, 2009, the related consolidated statements of operations and consolidated statements of cash flows for the quarter ended September 27, 2009 as presented in this press release are unaudited.

Regulated Information

This press release, the US GAAP consolidated financial statements and the IFRS consolidated financial statements published on www.asml.com comprise regulated information within the meaning of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).

Forward Looking Statements

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

Page 5 of 5

EX-99.2

Exhibit 99.2

ASML 2009 Third Quarter Results Sales and orders rise as chip industry executes technology investment strategy October 14, 2009

Safe Harbor "Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers' products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

Agenda Business summary ASML business update Outlook and summary

Business summary

Q3 results Net sales of € 555 million, 24 systems shipped valued at € 459 million, service revenue at € 96 million Average selling price for new systems shipped is € 23.4 million Gross Margin of 34.4% Shipped 13 immersion systems including 2 used Booked net 35 systems, valued at € 777 million Backlog increased to € 1,353 million, 54 systems including 37 immersion tools

Total net sales M€ 1,543 2,465 2,529 3,582 3,768 Numbers have been rounded for readers' convenience. 2,954 318 453 685 629 949 919 184 329 616 763 942 930 844 277 370 611 533 958 934 697 555 526 785 548 1053 955 494 0 500 1000 1500 2000 2500 3000 3500 4000 4500 2003 2004 2005 2006 2007 2008 2009 Net sales Q4 Q3 Q2 Q1

Net system sales breakdown in value: Q3 2009 End-use Foundry 20% Numbers have been rounded for readers' convenience Technology I-Line 2% ArF immersion 84% ArF dry 4% USA 17% Korea 25% Sales in Units Region China 20% Taiwan 26% Memory 71% IDM 9% Singapore 12% KrF 10% 1 6 4 13 ArF immersion ArF dry KrF I-Line

Numbers have been rounded for readers' convenience. Consolidated statement of operations M€ Q 2 09 Q 3 09 Net sales 277 55 5 Gross profit Gross margin % 34 12.5 % 191 34.4 % R&D costs 118 11 5 SG&A costs 41 38 I ncome (loss) from operations Operating income % (12 5 ) - - 45 ..0% 3 9 6.9 % Net income (loss) Net income as a % of sales ( 104 ) - - 37.6 % 20 3.6 %

Key financial trends 2008 - 2009 Consolidated statement of operations M€ Numbers have been rounded for readers' convenience. Q3 08 Q4 08 Q1 09 Q2 09 Q3 09 Net Sales 696 494 184 277 55 5 Gross profit Gross margin % 265 38.1% 39 7.9% 12 6.7% 34 12.5% 191 34.4 % R&D 130 127 118 118 115 SG&A 52 47 41 41 38 Income (loss) from operations Operating income % 83 12.0% (135) - - 27 ..4% (147) - - 80.0% (125) - - 45.0% 3 9 6.9 % Net income (loss) Net income as a % of sales 73 10.5% (88) - - 17.8% (117) - - 63.8% (104) - - 37.6% 20 3.6 % Units sold 37 25 11 10 24 ASP New Systems 21.6 20.4 13.8 31.1 23. 4 Net Bookings Units 31 13 8 15 35

Cash flow M€ Numbers have been rounded for readers' convenience. Q2 09 Q3 09 Net income (loss) (104) 20 Adjustments to reconcile net income (loss) to net cash flows from operating activities; Impairment and obsolescence 48 30 Depreciation and amortization 32 39 Deferred income taxes (31) (4 ) Other non - - ca sh items 3 4 Change in assets and liabilities 114 (154) Net cash provided by (used in) operating activities 62 (65) Net cash provided by (used in) investing activities (34 ) (14 ) Net cash provided by (used in) financing activities (86) 5 Tota l FX effects 0 (1) Net increase (decrease) in cash and cash equivalents (58) (75 )

Balance sheet as of September 27, 2009 M€ Numbers have been rounded for readers' convenience. Assets Jun 2009 Sep 200 9 Cash and cash equivalents 1,093 31% 1,018 28 % Accounts receivable, net 213 6% 382 11 % Finance receivables, net 21 1% 21 1% Inventories, net 926 26% 882 25 % Other assets 274 8% 29 3 8% Tax asset s 269 7% 26 3 7% Fixed assets 749 21% 709 20 % Total assets 3,545 100% 3,568 100% Liabilities and shareholders' equity Jun 2009 Sep 2009 Current liabilities 941 26% 9 50 26% Non - - current liabilities 913 26% 912 26% Sharehol ders' equity 1,691 48% 1,706 48% Total liabilities and shareholders' equity 3,545 100% 3,568 100%

71% of backlog or € 958 million system sales carry shipment dates in the next 6 months (up from 59% in Q2) Booked 27 new tools at € 727 million, 8 used at € 50 million Note: Due to possible customer changes in delivery schedules and to cancellation of orders, our backlog at any particular date is not necessarily indicative of actual sales for any succeeding period Numbers have been rounded for readers' convenience Backlog as of September 27, 2009 New systems Backlog Used systems Backlog Total systems Backlog Units 4 6 8 54 Value M€ 1 , 284 M€ 69 M€ 1 , 353 ASP M€ 27.9 M€ 8.6 M€ 2 5 ..1

Backlog: value and litho units Backlog units 0 500 1000 1500 2000 2500 Jan 03 Jul 03 Jan 04 Jul 04 Jan 05 Jul 05 Jan 06 Jul 06 Jan 07 Jul 07 Jan 08 Jul 08 Jan 09 Jul 09 Backlog value M€ 0 50 100 150 200 250 300 Backlog value Systems

Taiwan Europe Singapore Korea USA Japan China 19 8 4 33 16 17 memory IDM Foundry 60 23 17 0 0 0 immersion KrF 1-line ArF dry 89 7 4 Backlog lithography in value per September 27, 2009 Total value M€ 1,353 Technology ArF immersion 89% KrF 7% ArF dry 4% Region USA 16% Taiwan 23% Korea 33% Europe 7% Japan 17% End-use Memory 60% IDM 23% Foundry 17% Numbers have been rounded for readers' convenience Singapore 4%

ASML business update

Technology conversions continue - minimal wafer capacity added Sales doubled from Q2 due to demand for advanced technology from: DRAM customers introducing new memory devices Foundry ramping 40nm products Memory customers buy new immersion tools to support manufacturing of the next node (5x and 4x nm) enabling bit growth without adding wafer capacity Foundry technology transition (4x nm) results in additional wafer manufacturing capacity at leading edge

Bookings activity by sector Q3 bookings are predominantly from DRAM and Foundry sectors in support of process shrinks NAND order activity negligible foundry idm memory 24 14 62 foundry idm memory 14 7 14 Bookings in value Bookings in units IDM 14% Foundry 24% Memory 62% IDM 20% Foundry 40% Memory 40%

Cash position remains solid Q3 cash & cash equivalents at € 1.018 billion remain above our target of € 1 billion even as we invest in working capital to prepare for sales growth as a result of: Stringent cost control Products sold out of inventory Net cash used in operations in Q3 is € 65 million as increasing sales level results in higher account receivables Q4 cash balance is expected at level similar to end Q3 2009

For double patterning 30 nm and smaller Productivity more than 175 wafers per hour Overlay less than 3 nm First TWINSCAN NXT:1950i shipped in Q3 as planned

TWINSCAN NXT - Proven performance Qualification data chuck 2 chuck 1 spec CD uniformity 0.9 0.6 1.1 0.9 3.5 nm Across Field 50nm Off Focus 0.6 2.2 nm Across Field Best Focus 1.2 3.2 nm Across Wafer Nominal Focus X = 1.6 Y = 1.7 1 2 3 4 5 6 7 8 0 2 4 Overlay [nm] Overlay: CD Uniformity: wafer

Outlook and summary

Q4 2009 outlook Net sales expected around € 550 million Gross margin expected of about 37% R&D is expected at € 115 million net of credit SG&A is expected at € 37 million Q4 2009 orders expected to be at least of similar value as Q3 2009 Tax rate for 2009 is expected below 20%

Summary Bookings of € 777 million in Q3 reflecting accelerated technology investments in DRAM and Foundry after 9 months of very low capital spending Q4 order intake is expected at least of similar value as Q3 2009 H2 2009 bookings is for deliveries in H1 2010 and will translate into significant sales growth versus current levels. This substantial order increase does not factor in a full worldwide economic recovery, which, if it materializes, could sustain H1 2010 sales level into H2 2010 We expect our cash balance in Q4 2009 to be at a similar level as per end Q3, even as we prepare to ramp NXT shipments in H1 2010 and to build EUV systems planned for delivery in H2 2010

Outlook We booked 35 systems worth € 777 million in the third quarter, nearly twice the level booked in the second quarter; this level reflects accelerated technology investments in the DRAM memory and Foundry segments after a 9 month period of very low capital spending. This recovery mainly supports new Integrated Circuits product introductions, not so much an overall significant wafer capacity increase ASML's Q3 order intake, and that of Q4 which we expect to be at least of similar value, is for deliveries in the first half of 2010 and will translate into significant sales growth versus Q3 levels. This substantial order increase does not factor in a full worldwide economic recovery, which, if it materializes, could sustain the first half sales level into the second half of 2010 ASML expects Q4 2009 net sales of around € 550 million and gross margin in Q4 2009 of about 37 percent. R&D expenditures are expected to be at € 115 million net of credits and SG&A costs are expected at € 37 million. We expect our cash balance in Q4 2009 to be at a similar level as per end- Q3, even as we prepare to ramp NXT shipments in the first half of 2010 and to build EUV systems planned for delivery in the second half of 2010

EX-99.3

Exhibit 99.3

ASML — Summary U.S. GAAP Consolidated Statements of Operations ¹

	Three months ended,						Nine months ended,
(in thousands EUR, except per share data)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net system sales		590,723			458,691			2,136,296			743,050
Net service and field option sales		105,770			96,581			323,562			272,447
Total net sales		696,493			555,272			2,459,858			1,015,497
Cost of sales		431,062			364,013			1,483,334			777,438
Gross profit on sales		265,431			191,259			976,524			238,059
Research and development costs, net of credits		130,157			115,166			388,657			351,371
Selling, general and administrative costs		51,933			37,537			165,628			119,510
Income (loss) from operations		83,341			38,556			422,239			(232,822	)
Interest income (expense)		7,059			(2,383	)		17,633			(3,652	)
Income (loss) from operations before income taxes		90,400			36,173			439,872			(236,474	)
(Provision for) benefit from income taxes		(17,106	)		(16,434	)		(29,478	)		35,069
Net income (loss)		73,294			19,739			410,394			(201,405	)
Basic net income (loss) per ordinary share		0.17			0.05			0.95			(0.47	)
Diluted net income (loss) per ordinary share2		0.17			0.05			0.94			(0.47	)
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,672			432,675			431,498			432,414
Diluted 2		434,491			434,975			434,859			432,414

ASML — Ratios and Other Data ¹

	Three months ended,						Nine months ended,
	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Gross profit as a % of net sales		38.1			34.4			39.7			23.4
Income (loss) from operations as a % of net sales		12.0			6.9			17.2			(22.9	)
Net income (loss) as a % of net sales		10.5			3.6			16.7			(19.8	)
Shareholders’ equity as a % of total assets		50.3			47.8			50.3			47.8
Income taxes as a % of income before income taxes		(18.9	)		(45.4	)		(6.7	)		(14.8	)
Sales of systems (in units)		37			24			126			45
ASP of systems sales (EUR million)		16.0			19.1			17.0			16.5
Value of backlog systems (EUR million)		1,028			1,353			1,028			1,353
Backlog systems (in units)		53			54			53			54
ASP of backlog systems (EUR million)		19.4			25.1			19.4			25.1
Value of booked systems (EUR million)		498			777			1,443			1,378
Net bookings (in units)		31			35			90			58
ASP of booked systems (EUR million)		16.1			22.2			16.0			23.8
Number of payroll employees in FTEs		6,907			6,529			6,907			6,529
Number of temporary employees in FTEs		1,610			917			1,610			917

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹

(in thousands EUR)	Dec 31, 2008		Sep 27, 2009
ASSETS
Cash and cash equivalents		1,109,184		1,018,028
Accounts receivable, net		463,273		382,065
Finance receivables, net		6,225		21,151
Current tax assets		87,560		—
Inventories, net		999,150		882,369
Deferred tax assets		71,780		68,962
Other assets		236,077		224,240
Total current assets		2,973,249		2,596,815
Finance receivables, net		31,030		—
Deferred tax assets		148,133		193,466
Other assets		88,197		68,061
Goodwill		131,453		128,595
Other intangible assets, net		26,692		19,037
Property, plant and equipment, net		540,640		561,684
Total non-current assets		966,145		970,843
Total assets		3,939,394		3,567,658
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,008,343		949,273
Long-term debt		647,050		660,191
Deferred and other tax liabilities		209,699		193,708
Provisions		15,495		13,506
Accrued liabilities and other liabilities		70,038		44,709
Total non-current liabilities		942,282		912,114
Total liabilities		1,950,625		1,861,387
Shareholders’ equity		1,988,769		1,706,271
Total liabilities and shareholders’ equity		3,939,394		3,567,658

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		73,294			19,739			410,394			(201,405	)
Depreciation and amortization		28,625			39,302			84,102			108,838
Impairment		552			9,050			2,196			16,029
Loss on disposals of property, plant and equipment		1,413			859			3,827			3,037
Share-based payments		3,686			2,786			10,362			8,879
Allowance for doubtful debts		(206	)		672			(313	)		1,836
Allowance for obsolete inventory		21,295			20,840			53,851			86,872
Deferred income taxes		2,421			(4,461	)		(31,447	)		(62,695	)
Change in assets and liabilities		(110,227	)		(154,188	)		(114,790	)		117,324
Net cash provided by (used in) operating activities		20,853			(65,401	)		418,182			78,715
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68,237	)		(13,511	)		(188,710	)		(97,267	)
Proceeds from sale of property, plant and equipment		—			—			—			6,877
Purchases of intangible assets		(35	)		—			(35	)		—
Net cash used in financing activities		(68,272	)		(13,511	)		(188,745	)		(90,390	)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(394	)		—			(107,841	)		(86,486	)
Purchase of shares in conjunction with share-based payment plans		—			—			(87,605	)		—
Net proceeds from issuance of shares and stock options		1,439			4,183			4,966			4,714
Excess tax benefits (deficiencies) from stock options		(1,946	)		715			4,027			963
Net proceeds from other long-term debt		—			—			—			32
Redemption and/or repayment of debt		(1,280	)		(4	)		(1,280	)		(13	)
Net cash provided by (used in) financing activities		(2,181	)		4,894			(187,733	)		(80,790	)
Net cash flows		(49,600	)		(74,018	)		41,704			(92,465	)
Effect of changes in exchange rates on cash		1,695			(614	)		(347	)		1,309
Net increase (decrease) in cash & cash equivalents		(47,905	)		(74,632	)		41,357			(91,156	)

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR, except per share data)	2008			2008			2009			2009			2009
Net system sales		590.7			380.5			101.1			183.3			458.7
Net service and field option sales		105.8			113.3			82.5			93.3			96.6
Total net sales		696.5			493.8			183.6			276.6			555.3
Cost of sales		431.1			454.8			171.2			242.2			364.0
Gross profit on sales		265.4			39.0			12.4			34.4			191.3
Research and development costs, net of credits		130.2			127.5			118.3			117.9			115.2
Selling, general and administrative costs		51.9			46.7			41.0			41.0			37.5
Income (loss) from operations		83.3			(135.2	)		(146.9	)		(124.5	)		38.6
Interest income (expense)		7.1			5.0			(1.1	)		(0.2	)		(2.4	)
Income (loss) from operations before income taxes		90.4			(130.2	)		(148.0	)		(124.7	)		36.2
(Provision for) benefit from income taxes		(17.1	)		42.2			30.8			20.7			(16.5	)
Net income (loss)		73.3			(88.0	)		(117.2	)		(104.0	)		19.7
Basic net income (loss) per ordinary share		0.17			(0.20	)		(0.27	)		(0.24	)		0.05
Diluted net income (loss) per ordinary share 2		0.17			(0.20	)		(0.27	)		(0.24	)		0.05
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,672			431,989			432,112			432,454			432,675
Diluted 2		434,491			431,989			432,112			432,454			434,975

ASML — Quarterly Summary Ratios and other data ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
	2008			2008			2009			2009			2009
Gross profit as a % of net sales		38.1			7.9			6.7			12.5			34.4
Income (loss) from operations as a % of net sales		12.0			(27.4	)		(80.0	)		(45.0	)		6.9
Net income (loss) as a % of net sales		10.5			(17.8	)		(63.8	)		(37.6	)		3.6
Shareholders’ equity as a % of total assets		50.3			50.5			48.0			47.7			47.8
Income taxes as a % of income before income taxes		(18.9	)		(32.4	)		(20.8	)		(16.6	)		(45.4	)
Sales of systems (in units)		37			25			11			10			24
ASP of system sales (EUR million)		16.0			15.2			9.2			18.3			19.1
Value of backlog systems (EUR million)		1,028			755			853			1,064			1,353
Backlog systems (in units)		53			41			38			43			54
ASP of backlog systems (EUR million)		19.4			18.4			22.4			24.7			25.1
Value of booked systems (EUR million)		498			127			207			394			777
Net bookings (in units)		31			13			8			15			35
ASP of booked systems (EUR million)		16.1			9.8			25.8			26.3			22.2
Number of payroll employees in FTEs		6,907			6,930			6,715			6,597			6,529
Number of temporary employees in FTEs		1,610			1,329			959			868			917

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹

	Sep 28,		Dec 31,		Mar 29,		Jun 28,		Sep 27,
(in millions EUR)	2008		2008		2009		2009		2009
ASSETS
Cash and cash equivalents		1,313.0		1,109.2		1,151.0		1,092.7		1,018.0
Accounts receivable, net		536.1		463.3		291.6		213.5		382.1
Finance receivables, net		7.4		6.2		6.2		0.1		21.1
Current tax assets		—		87.6		—		—		—
Inventories, net		1,134.0		999.1		936.8		926.1		882.4
Deferred tax assets		82.8		71.8		74.9		70.5		69.0
Other assets		261.4		236.1		240.6		220.2		224.2
Total current assets		3,334.7		2,973.3		2,701.1		2,523.1		2,596.8
Finance receivables, net		30.7		31.0		29.2		20.6		—
Deferred tax assets		139.4		148.1		173.2		198.9		193.5
Other assets		50.6		88.2		89.5		53.8		68.1
Goodwill		129.2		131.5		139.7		134.5		128.6
Other intangible assets, net		28.8		26.7		25.6		22.3		19.0
Property, plant and equipment, net		503.1		540.6		586.6		591.9		561.7
Total non-current assets		881.8		966.1		1,043.8		1,022.0		970.9
Total assets		4,216.5		3,939.4		3,744.9		3,545.1		3,567.7
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,273.0		1,008.3		1,017.5		940.9		949.3
Long-term debt		596.7		647.1		661.4		651.9		660.2
Deferred and other tax liabilities		215.2		209.7		204.9		200.6		193.7
Provisions		—		15.5		16.9		14.8		13.5
Accrued liabilities and other liabilities		8.8		70.0		48.2		45.6		44.7
Total non-current liabilities		820.7		942.3		931.4		912.9		912.1
Total liabilities		2,093.7		1,950.6		1,948.9		1,853.8		1,861.4
Shareholders’ equity		2,122.8		1,988.8		1,796.0		1,691.3		1,706.3
Total liabilities and shareholders’ equity		4,216.5		3,939.4		3,744.9		3,545.1		3,567.7

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR)	2008			2008			2009			2009			2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		73.3			(88.0	)		(117.2	)		(104.0	)		19.7
Depreciation and amortization		28.6			35.1			37.9			31.6			39.3
Impairment		0.6			22.9			2.6			4.4			9.1
Loss (gain) on disposals of property, plant and equipment		1.4			0.4			2.6			(0.4	)		0.9
Share-based payments		3.7			3.2			3.5			2.6			2.8
Allowance for doubtful debts		(0.2	)		0.5			—			1.2			0.7
Allowance for obsolete inventory		21.3			85.8			22.1			43.9			20.8
Deferred income taxes		2.4			(2.7	)		(27.0	)		(31.2	)		(4.5	)
Change in assets and liabilities		(110.2	)		(194.6	)		157.7			113.8			(154.2	)
Net cash provided by (used in) operating activities		20.9			(137.4	)		82.2			61.9			(65.4	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68.3	)		(71.1	)		(43.9	)		(39.9	)		(13.5	)
Proceeds from sale of property, plant and equipment		—			—			1.2			5.7			—
Net cash used in investing activities		(68.3	)		(71.1	)		(42.7	)		(34.2	)		(13.5	)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(0.4	)		—			—			(86.5	)		—
Net proceeds from issuance of shares and stock options		1.4			6.5			0.1			0.4			4.2
Excess tax benefits (deficiencies) from stock options		(1.9	)		(1.9	)		(0.2	)		0.5			0.7
Net proceeds from other long-term debt		—			—			—			0.1			—
Redemption and/or repayment of debt		(1.3	)		(1.1	)		—			—			—
Net cash provided by (used in) financing activities		(2.2	)		3.5			(0.1	)		(85.5	)		4.9
Net cash flows		(49.6	)		(205.0	)		39.4			(57.8	)		(74.0	)
Effect of changes in exchange rates on cash		1.7			1.2			2.4			(0.5	)		(0.7	)
Net increase (decrease) in cash & cash equivalents		(47.9	)		(203.8	)		41.8			(58.3	)		(74.7	)

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as sales transactions and forecasted purchase transactions. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of September 27, 2009 EUR 39.8 million loss is classified as other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 0.9 million loss representing the total anticipated loss to be released to cost of sales when the forecasted revenue and purchase transactions occur.

ASML — Reconciliation U.S. GAAP — IFRS ¹

Net income	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net income (loss) under U.S. GAAP		73,294			19,739			410,394			(201,405	)
Share-based payments (see Note 1)		(2,492	)		1,415			(3,009	)		2,311
Capitalization of development costs (see Note 2)		14,867			24,504			55,197			57,779
Reversal of write-downs (see Note 3)		—			28,509			—			28,509
Income taxes (see Note 4)		(3,119	)		(1,350	)		(3,081	)		(3,407	)
Net income (loss) under IFRS		82,550			72,817			459,501			(116,213	)

Shareholders’ equity	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in thousands EUR)	2008			2008			2009			2009			2009
Shareholders’ equity under U.S. GAAP		2,122,848			1,988,769			1,795,951			1,691,240			1,706,271
Share-based payments (see Note 1)		(7,904	)		(6,537	)		(7,088	)		(4,918	)		(460	)
Capitalization of development costs (see Note 2)		193,780			201,717			215,452			235,945			259,665
Reversal of write-downs (see Note 3)		—			—			—			—			28,509
Income taxes (see Note 4)		5,969			4,794			3,361			2,797			1,370
Shareholders’ equity under IFRS		2,314,693			2,188,743			2,007,676			1,925,064			1,995,355

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies ASC 718 “Share-Based Payment” which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements.

Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures which are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies ASC 730, “Accounting for Research and Development Costs”. In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Reversal of write-downs

Under IFRS, ASML applies IAS 2 (revised), “Inventories”. In accordance with IAS 2, reversal of a prior period write-down as a result of a subsequent increase in value of inventory should be recognized in the period in which the value increase occurs.

Under U.S. GAAP, ASML applies ASC 330 Inventory. In accordance with ASC 330 reversal of a write-down is prohibited as a write-down creates a new cost basis.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1	All quarterly information in this press release is unaudited.
2	The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.

EX-99.4

Exhibit 99.4

ASML — Summary IFRS Consolidated Income Statement ¹

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net system sales		590,723			458,691			2,136,296			743,050
Net service and field option sales		105,770			96,581			323,562			272,447
Total net sales		696,493			555,272			2,459,858			1,015,497
Cost of sales		452,713			333,716			1,539,628			778,645
Gross profit on sales		243,780			221,556			920,230			236,852
Research and development costs, net of credits		88,571			74,536			258,360			235,072
Selling, general and administrative costs		52,245			36,810			165,272			117,695
Operating income (loss)		102,964			110,210			496,598			(115,915	)
Interest income (charges)		6,599			(2,231	)		15,147			(261	)
Income (loss) before income taxes		109,563			107,979			511,745			(116,176	)
Provision for income taxes		(27,013	)		(35,162	)		(52,244	)		(37	)
Net income (loss)		82,550			72,817			459,501			(116,213	)

ASML — Summary IFRS Consolidated Statement of Financial Position ¹

(in thousands EUR)	Dec 31, 2008		Sep 27, 2009
ASSETS
Property, plant and equipment		550,921		569,396
Goodwill		139,626		136,590
Other intangible assets		289,530		359,149
Deferred tax assets		225,544		258,677
Finance receivables		31,030		—
Derivative financial instruments		53,206		48,507
Other assets		29,449		14,572
Total non-current assets		1,319,306		1,386,891
Inventories		999,150		920,636
Current tax assets		87,560		—
Derivative financial instruments		39,240		44,584
Finance receivables		6,225		21,151
Accounts receivable		463,273		382,065
Other assets		170,680		159,051
Cash and cash equivalents		1,109,184		1,018,028
Total current assets		2,875,312		2,545,515
Total assets		4,194,618		3,932,406
EQUITY AND LIABILITIES
Equity		2,188,743		1,995,355
Long-term debt		661,483		667,188
Derivative financial instruments		19,743		1,665
Deferred and other tax liabilities		260,360		266,709
Provisions		15,495		13,506
Accrued liabilities and other liabilities		50,293		43,044
Total non-current liabilities		1,007,374		992,112
Accounts payable		193,690		222,206
Accrued liabilities and other liabilities		732,043		661,489
Current tax liabilities		20,039		35,367
Derivative financial instruments		48,051		23,469
Provisions		4,678		2,408
Total current liabilities		998,501		944,939
Total equity and liabilities		4,194,618		3,932,406

ASML — Summary IFRS Consolidated Statement of Cash Flows ¹

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		82,550			72,817			459,501			(116,213	)
Depreciation and amortization		50,110			47,942			140,051			150,323
Impairment charges		552			9,050			2,196			16,029
Loss on disposals of property, plant and equipment		1,413			859			3,827			3,037
Share-based payments		3,581			2,786			9,858			8,879
Allowance for doubtful debts		(206	)		672			(313	)		1,836
Allowance for obsolete inventory		21,295			(17,427	)		53,851			48,605
Change in assets and liabilities		(98,921	)		(139,019	)		(116,686	)		88,688
Net cash provided by (used in) operating activities		60,374			(22,320	)		552,285			201,184
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68,237	)		(13,511	)		(188,710	)		(97,267	)
Proceeds from sale of property, plant and equipment		—			—			—			6,877
Purchases of intangible assets		(41,502	)		(40,631	)		(130,111	)		(116,300	)
Net cash used in investing activities		(109,739	)		(54,142	)		(318,821	)		(206,690	)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of shares in conjunction with share-based payment plans		—			—			(87,605	)		—
Net proceeds from issuance of shares and stock options		1,439			4,183			4,966			4,714
Dividend paid		(394	)		—			(107,841	)		(86,486	)
Net proceeds from other long term debt		—			—			—			32
Redemption and / or repayment of debt		(1,280	)		(1,739	)		(1,280	)		(5,219	)
Net cash provided by (used in) financing activities		(235	)		2,444			(191,760	)		(86,959	)
Net cash flows		(49,600	)		(74,018	)		41,704			(92,465	)
Effect of changes in exchange rates on cash		1,695			(614	)		(347	)		1,309
Net increase (decrease) in cash & cash equivalents		(47,905	)		(74,632	)		41,357			(91,156	)

ASML — Quarterly Summary IFRS Consolidated Income Statement ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR)	2008			2008			2009			2009			2009
Net system sales		590.7			380.5			101.1			183.3			458.7
Net service and field option sales		105.8			113.3			82.5			93.3			96.6
Total net sales		696.5			493.8			183.6			276.6			555.3
Cost of sales		452.7			476.5			196.3			248.6			333.7
Gross profit (loss) on sales		243.8			17.3			(12.7	)		28.0			221.6
Research and development costs, net of credits		88.6			95.8			78.0			82.5			74.5
Selling, general and administrative costs		52.2			47.7			42.0			38.9			36.9
Operating income (loss)		103.0			(126.2	)		(132.7	)		(93.4	)		110.2
Interest income (charges)		6.6			2.8			3.2			(1.3	)		(2.2	)
Income (loss) before income taxes		109.6			(123.4	)		(129.5	)		(94.7	)		108.0
(Provision for) benefit from income taxes		(27.0	)		40.8			21.7			13.4			(35.2	)
Net income (loss)		82.6			(82.6	)		(107.8	)		(81.3	)		72.8

ASML — Quarterly Summary IFRS Consolidated Statement of Financial Position ¹

	Sep 28,		Dec 31,		Mar 29,		Jun 28,		Sep 27,
(in millions EUR)	2008		2008		2009		2009		2009
ASSETS
Property, plant and equipment		503.1		550.9		596.1		600.5		569.4
Goodwill		137.3		139.6		148.4		142.9		136.6
Other intangible assets		281.3		289.5		306.1		330.4		359.1
Deferred tax assets		228.6		225.6		244.6		268.7		258.7
Finance receivables		30.7		31.0		29.2		20.6		—
Derivative financial instruments		12.3		53.2		70.0		33.4		48.5
Other assets		32.6		29.5		14.2		15.2		14.6
Total non-current assets		1,225.9		1,319.3		1,408.6		1,411.7		1,386.9
Inventories		1,134.0		999.1		936.8		926.1		920.6
Current tax assets		—		87.6		—		—		—
Derivative financial instruments		21.0		39.2		33.6		37.9		44.6
Finance receivables		7.4		6.2		6.2		0.1		21.1
Accounts receivable		536.1		463.3		291.6		213.5		382.1
Other assets		210.6		170.7		186.0		162.1		159.1
Cash and cash equivalents		1,313.0		1,109.2		1,151.0		1,092.7		1,018.0
Total current assets		3,222.1		2,875.3		2,605.2		2,432.4		2,545.5
Total assets		4,448.0		4,194.6		4,013.8		3,844.1		3,932.4
EQUITY AND LIABILITIES
Equity		2,314.7		2,188.7		2,007.7		1,925.1		1,995.4
Long-term debt		591.0		661.5		671.5		660.5		667.2
Derivative financial instruments		0.9		19.7		1.6		1.0		1.7
Deferred and other tax liabilities		256.9		260.4		258.1		263.6		266.7
Provisions		—		15.5		16.9		14.8		13.5
Accrued liabilities and other liabilities		7.8		50.3		46.7		44.6		43.0
Total non-current liabilities		856.6		1,007.4		994.8		984.5		992.1
Accounts payable		271.0		193.7		165.2		234.6		222.2
Accrued liabilities and other liabilities		948.1		732.0		789.8		652.4		661.5
Current tax liabilities		42.4		20.0		11.2		19.9		35.3
Derivative financial instruments		15.2		48.1		40.6		25.0		23.5
Provisions		—		4.7		4.5		2.6		2.4
Total current liabilities		1,276.7		998.5		1,011.3		934.5		944.9
Total equity and liabilities		4,448.0		4,194.6		4,013.8		3,844.1		3,932.4

ASML — Quarterly Summary IFRS Consolidated Statement of Cash Flows ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR)	2008			2008			2009			2009			2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		82.6			(82.6	)		(107.8	)		(81.3	)		72.8
Depreciation and amortization		50.1			57.2			63.6			38.7			47.9
Impairment charges		0.6			41.2			2.6			4.4			9.1
Loss on disposals of property, plant and equipment		1.4			0.4			2.6			(0.4	)		0.9
Share-based payments		3.6			3.0			3.5			2.6			2.8
Allowance for doubtful debts		(0.2	)		0.5			—			1.2			0.7
Allowance for obsolete inventory		21.3			85.8			22.1			43.9			(17.4	)
Change in assets and liabilities		(99.0	)		(215.3	)		137.4			90.4			(139.1	)
Net cash provided by (used in) operating activities		60.4			(109.8	)		124.0			99.5			(22.3	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68.3	)		(71.1	)		(43.9	)		(39.9	)		(13.5	)
Proceeds from sale of property, plant and equipment		—			—			1.2			5.7			—
Purchases of intangible assets		(41.4	)		(49.4	)		(40.3	)		(35.4	)		(40.6	)
Net cash used in investing activities		(109.7	)		(120.5	)		(83.0	)		(69.6	)		(54.1	)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(0.4	)		—			—			(86.5	)		—
Net proceeds from issuance of shares and stock options		1.4			6.5			0.1			0.4			4.2
Net proceeds from other long-term debt		—			19.9			—			0.1			—
Redemption and/or repayment of debt		(1.3	)		(1.1	)		(1.7	)		(1.7	)		(1.8	)
Net cash provided by (used in) financing activities		(0.3	)		25.3			(1.6	)		(87.7	)		2.4
Net cash flows		(49.6	)		(205.0	)		39.4			(57.8	)		(74.0	)
Effect of changes in exchange rates on cash		1.7			1.2			2.4			(0.5	)		(0.7	)
Net increase (decrease) in cash & cash equivalents		(47.9	)		(203.8	)		41.8			(58.3	)		(74.7	)

ASML — Notes to the Summary IFRS Consolidated Financial Statements

Basis of Presentation

ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the EU — accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’), except otherwise indicated.

For internal and external reporting purposes, ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP is ASML’s primary accounting standard for the Company’s setting of financial and operational performance targets.

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

In general, ASML recognizes the revenue from the sale of a system upon shipment and the revenue from the installation of a system upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in our clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, we have never failed to successfully complete installation of a system at a customer’s premises.

A portion of our revenue is derived from contractual arrangements with our customers that have multiple deliverables, such as installation and training services, prepaid service contracts and prepaid extended optic warranty contracts. The revenue relating to the undelivered elements of the arrangements is deferred until delivery of these elements. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid service contracts and prepaid extended optic warranty contracts is recognized over the term of the contract.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as sales transactions and forecasted purchase transactions. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of September 27, 2009 EUR 39.8 million loss is classified as other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 0.9 million loss representing the total anticipated gain to be released to cost of sales when the forecasted revenue and purchase transactions occur.

ASML — Reconciliation U.S. GAAP — IFRS ¹

Net income	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net income (loss) under U.S. GAAP		73,294			19,739			410,394			(201,405	)
Share-based payments (see Note 1)		(2,492	)		1,415			(3,009	)		2,311
Capitalization of development costs (see Note 2)		14,867			24,504			55,197			57,779
Reversal of write-downs (see Note 3)		—			28,509			—			28,509
Income taxes (see Note 4)		(3,119	)		(1,350	)		(3,081	)		(3,407	)
Net income (loss) under IFRS		82,550			72,817			459,501			(116,213	)

Shareholders' equity	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in thousands EUR)	2008			2008			2009			2009			2009
Shareholders’ equity under U.S. GAAP		2,122,848			1,988,769			1,795,951			1,691,240			1,706,271
Share-based payments (see Note 1)		(7,904	)		(6,537	)		(7,088	)		(4,918	)		(460	)
Capitalization of development costs (see Note 2)		193,780			201,717			215,452			235,945			259,665
Reversal of write-downs (see Note 3)		—			—			—			—			28,509
Income taxes (see Note 4)		5,969			4,794			3,361			2,797			1,370
Shareholders’ equity under IFRS		2,314,693			2,188,743			2,007,676			1,925,064			1,995,355

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies ASC 718 “Share-Based Payment” which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures which are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies ASC 730, “Accounting for Research and Development Costs”. In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Reversal of write-downs

Under IFRS, ASML applies IAS 2 (revised), “Inventories”. In accordance with IAS 2, reversal of a prior period write-down as a result of a subsequent increase in value of inventory should be recognized in the period in which the value increase occurs.

Under U.S. GAAP, ASML applies ASC 330 Inventory. In accordance with ASC 330 reversal of a write-down is prohibited as a write-down creates a new cost basis.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

¹ All quarterly information in this press release is unaudited.